MindWalk Holdings (HYFT) Interest & Investment Income (2024 - 2026)

MindWalk Holdings (HYFT) reported Interest & Investment Income of $50439.9 for Q1 2026, up 123.71% year-over-year from $22547.0 in Q1 2025, and up 74.92% quarter-over-quarter from $28835.2 in Q4 2025.

MindWalk Holdings (HYFT) Interest & Investment Income (2024 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has 3 years of Interest & Investment Income data on file, last reported at $50439.9 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 597,319.59
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 305,000.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 103,341.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 114.80 Mn
9 Abivax 94.26 Bn 94.26 Bn - -14.79 Mn
10 MindWalk Holdings 166.20 Mn 156.06 Mn 1.78 50,439.88

Historic Data

Download Data
DateValue
Jan 31, 2026 50,439.88
Oct 31, 2025 28,835.16
Jan 31, 2025 -212,736.91
Oct 31, 2024 -87,142.36
Jan 31, 2024 19,232.76